Literature DB >> 10101001

Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB.

A B Lentsch1, B J Czermak, N M Bless, N Van Rooijen, P A Ward.   

Abstract

Acute inflammatory injury in rat lung induced by deposition of immunoglobulin G immune complexes requires expression of cytokines and chemokines as well as activation of the transcription factor nuclear factor (NF)-kappaB. There is little direct evidence regarding the role of alveolar macrophages in these activation events. In the present studies, rat lungs were depleted of alveolar macrophages by airway instillation of liposome-encapsulated dichloromethylene diphosphonate. These procedures, which greatly reduced the number of retrievable alveolar macrophages, suppressed activation of lung NF-kappaB in the inflammatory model. In addition, bronchoalveolar lavage levels of tumor necrosis factor-alpha (TNF-alpha) and the CXC chemokine, macrophage inflammatory protein-2, were substantially reduced. In parallel, upregulation of the lung vascular adhesion molecule, intercellular adhesion molecule-1, was greatly reduced by intrapulmonary instillation of phosphonate-containing liposomes. Neutrophil accumulation and development of lung injury were also substantially diminished. Lung instillation of TNF-alpha in alveolar macrophage-depleted rats restored the NF-kappaB activation response in whole lung. These data suggest that, in this inflammatory model, initial activation of NF-kappaB occurs in alveolar macrophages and the ensuing production of TNF-alpha may propagate NF-kappaB activation to other cell types in the lung.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10101001     DOI: 10.1165/ajrcmb.20.4.3414

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  36 in total

1.  Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.

Authors:  M S Mulligan; A B Lentsch; M Huber-Lang; R F Guo; V Sarma; C D Wright; T R Ulich; P A Ward
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury.

Authors:  John A Belperio; Michael P Keane; Marie D Burdick; Vedang Londhe; Ying Ying Xue; Kewang Li; Roderick J Phillips; Robert M Strieter
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Map kinase phosphatase 5 protects against sepsis-induced acute lung injury.

Authors:  Feng Qian; Jing Deng; Benjamin N Gantner; Richard A Flavell; Chen Dong; John W Christman; Richard D Ye
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

Review 4.  Stem cells in sepsis and acute lung injury.

Authors:  Sushma K Cribbs; Greg S Martin
Journal:  Am J Med Sci       Date:  2011-04       Impact factor: 2.378

5.  Bactericidal function of alveolar macrophages in mechanically ventilated rabbits.

Authors:  Nina G Hall; Yuliang Liu; Judy M Hickman-Davis; Glenda C Davis; Carpantato Myles; Eric J Andrews; Sadis Matalon; John D Lang
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-10       Impact factor: 6.914

6.  C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

Authors:  Nelli Shushakova; Julia Skokowa; Jurriaan Schulman; Ulrich Baumann; Jörg Zwirner; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

7.  Thiol-Redox Regulation in Lung Development and Vascular Remodeling.

Authors:  Gaston Ofman; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2019-03-04       Impact factor: 8.401

8.  Evaluation of early macrophage activation and NF-kappaB activity in pulmonary injury caused by deep hypothermia circulatory arrest: an experimental study.

Authors:  Jing-hao Zheng; Bo-tao Gao; Zu-ming Jiang; Xiao-qing Yu; Zhi-wei Xu
Journal:  Pediatr Cardiol       Date:  2009-12-03       Impact factor: 1.655

9.  Activator protein-1 activation in acute lung injury.

Authors:  Ren-Feng Guo; Alex B Lentsch; J Vidya Sarma; Lei Sun; Niels C Riedemann; Shannon D McClintock; Stephanie R McGuire; Nico Van Rooijen; Peter A Ward
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 10.  Targeted treatment in COPD: a multi-system approach for a multi-system disease.

Authors:  David Anderson; William Macnee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.